A transformative product release from one of Kansas City’s leading healthtech companies coincides with a meaningful funding round — marking a new chapter in workers’ compensation, as well as for Bardavon’s recently announced new CEO, the company said.
Financial details of the round — led by WestCap and NewRoad Capital Partners, with participation from KCRise Fund and others — were undisclosed, but Alex Benson, CEO of the leading workers’ compensation and musculoskeletal (MSK) health company, emphasized continued participation by investors in Bardavon‘s previous Series A, B, and C raises.